Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients.

Ursodeoxycholic acid treatment is associated with improvement of liver stiffness in cystic fibrosis patients.

Resource Type

CF Research News

Authors

van der Feen C
van der Doef HP
van der Ent CK
Houwen RH

References

J Cyst Fibros. 2016 Jul 29. pii: S1569-1993(16)30566-5.

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Keywords

Cystic fibrosis liver disease [3]
Fibroscan [4]
Liver stiffness measurement [5]
Ursodeoxycholic acid [6]

Date

Friday, July 29, 2016

Featured resource article

No
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/ursodeoxycholic-acid-treatment-associated-improvement-liver

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00060R2_FINAL_Houwen_16092016.pdf [2] http://www.ncbi.nlm.nih.gov/pubmed/?term=URSODEOXYCHOLIC%20ACID%20TREATMENT%20IS%20ASSOCIATED%20WITH%20IMPROVEMENT%20OF%20LIVER%20STIFFNESS%20IN%20CYSTIC%20FIBROSIS%20PATIENTS [3] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-liver-disease [4] https://www.ecfs.eu/research-article-keywords/fibroscan [5] https://www.ecfs.eu/research-article-keywords/liver-stiffness-measurement [6] https://www.ecfs.eu/research-article-keywords/ursodeoxycholic-acid